Oncology Nursing News

Articles

FDA Approves Zanubrutinib for CLL/SLL

January 19, 2023

The FDA has approved zanubrutinib for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. The prescribing label comes with warnings for hemorrhage, infections, cytopenias, second primary malignancies, and cardiac arrythmias.